In a report released today, Steven Seedhouse from Raymond James maintained a Buy rating on NGM Biopharmaceuticals (NGM), with a price target of ...
The post Raymond James Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM) appeared first on Smarter Analyst.
In a report released today, Steven ...
https://www.smarteranalyst.com/new-blurbs/raymond-james-sticks-to-its-buy-rating-for-ngm-biopharmaceuticals-ngm-2/#SmarterAnalyst
You must login before you can post a comment.